Stem cell specialist Mesoblast (MSB) has reported encouraging results from a Phase II trial of its remestemcel-L product in treating lung disease. Under the trial, 60 patients with chronic obstructive pulmonary disease (COPD) were tested against a placebo control group to monitor the efficacy of remestemcel-L. COPD refers to a group of lung diseases that all block airflow and make it difficult to breathe
DetailsCategory: DNA RNA and CellsPublished on Monday, 01 June 2020 18:32Hits: 295 The Phase 2 study will assess the safety and efficacy of Longeveron's stem cell treatment under Japan's accelerated regulatory pathway for regenerative medicine.
Trusted Business Insights answers what are the scenarios for growth and recovery and whether there will be any lasting structural impact from the unfolding crisis for the Stem Cell Cartilage Regeneration market.
MedicalResearch.com Interview with: Charles-de-SM.D., Ph.D.Rio de Janeiro, Brazil MedicalResearch.com: What is the background for this study?
Microvascular obstruction (MVO) after primary percutaneous coronary intervention (pPCI) is identified as an independent risk factor for poor prognosis in patients with acute myocardial infarction (AMI). The inflammatory response induced by ischemia and reperfusion (I/R) injury is considered one of the main mechanisms of MVO. Mesenchymal stem cells (MSCs) are a unique stromal cell type that confers an immunomodulatory effect in cardiac disease
The global Mesenchymal Stem Cells market study presents an all in all compilation of the historical, current and future outlook of the market as well as the factors responsible for such a growth. With SWOT analysis, the business study highlights the strengths, weaknesses, opportunities and threats of each Mesenchymal Stem Cells market player in a comprehensive way. Further, the Mesenchymal Stem Cells market report emphasizes the adoption pattern of the Mesenchymal Stem Cells across various industries
Others In addition, the report categorizes product type and end uses as dynamic market segments that directly impact the growth potential and roadmap of the target market. The report highlights the core developments that are common to all regional hubs and their subsequent impact on the holistic growth path of the Mesenchymal Stem Cells market worldwide
Researchstore.biz unravels its new study titled Global Human Primary Cells Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 which provides industry analysis, important insights, and a competitive and useful advantage to the pursuers. The report analyzes different segments and offers the current and future prospects of each segment.
The excessive inflammatory response seen in the most serious cases of Covid-19, along with shortages of ventilators, has caused a healthcare crisis in many countries around the world. Could cell therapy provide an answer to this dilemma? Most people who become infected with Covid-19 experience symptoms such as a dry cough and mild fever, and recover without medical care.
Biotech stocks closed the week ended May 22 higher, with stray clinical readouts and COVID-19 drug- and vaccine-related news moving stocks in the sector. Surface Oncology Inc (NASDAQ: SURF) was one of the biggest advancers of the week after it announced an oncology partnership with Merck & Co., Inc
Recent Comments